20Oct2017
20Oct2017

Novadip is hiring a QA Support

Find the job description here
29Jun2017

Novadip is hiring

Apply for one of our vacant positions, find all job descriptions here !  
29May2017

NOVADIP appoints Eric Paul Pâques as Chairman of the Board

Mont-Saint-Guibert, Belgium – May 30, 2017 – Advanced biopharmaceutical company NOVADIP BIOSCIENCES, which pioneers the growth of 3-dimensional tissues derived from adipose stem cells to ...
20Jun2016

Fast-growing biopharmaceutical company NOVADIP develops its product portfolio and moves to new premises offering on-site R&D and GMP facilities

Mont-Saint-Guibert, Belgium - June 21, 2016 - NOVADIP BIOSCIENCES, a biopharmaceutical spin-off company of Université catholique de Louvain, announces the official opening of its new site in ...
09Sep2015

Novadip closes EUR 28 million Series A Round with US and Belgian investors to advance breakthrough cell therapy pipeline

EN - FR - NL Louvain-la-Neuve, Belgium - September 10, 2015 – Novadip Biosciences, a biopharmaceutical spin-off company of Université catholique de Louvain announces the successful closing of a ...
10Jun2016

L'Echo : Les Belges présents en force à la plus grande bourse biotech du globe

Lien vers l'article : Les Belges présents en force à la plus grande bourse biotech du globe
28May2015
09May2015

L’Echo : Atelier plasticine

Pour reconstruire le tissu osseux, Novadip Biosciences a mis au point un genre de plasticine faite à partir des cellules souches du patient. Ultra pratique pour le chirurgie, ultra pratique pour ...
16Mar2013

Critical size bone defect reconstruction by an autologous 3D osteogenic-like tissue derived from differentiated adipose MSCs

For critical size bone defects and bone non-unions, bone tissue engineering using osteoblastic differentiated adipose mesenchymal stem cells (AMSCs) is limited by the need for a biomaterial to ...
27Aug2011

The enhanced performance of bone allografts using osteogenic-differentiated adipose-derived mesenchymal stem cells

Adipose tissue was only recently considered as a potential source of mesenchymal stem cells (MSCs) for bone tissue engineering. To improve the osteogenicity of acellular bone allografts, adipose ...